🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseAlcohol + MASH + GLP-1 — July 2024 Page 4

Alcohol + MASH + GLP-1 — July 2024

carlos_SATX Sun, Oct 19, 2025 at 3:58 PM 44 replies 1,456 viewsPage 4 of 9
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Nov 1, 2025 at 7:24 PM#16

Adding the clinical framing, because it changes how the question reads. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Correct me if the detail matters more than I have assumed.

Last edited: Nov 1, 2025 at 10:24 PM
25 23amsterdam_pete, LondonLisa, mike_nyc and 22 others
Reply Quote Save Share Report
emily_PDX
Member
245
1,123
Nov 2024
Portland, OR
Nov 3, 2025 at 3:29 PM#17
TirzTom said:
If you are going to change something, change one thing and give it long enough to express itself.

Adding the part of the answer the thread has not reached. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

Last edited: Nov 3, 2025 at 5:29 PM
26 24PharmD_Rodriguez, julia.endo, JessicaM_2024 and 23 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Nov 5, 2025 at 11:34 AM#18

One concrete data point for the thread. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

27 0LondonLisa, mike_nyc, VendorMark and 24 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Nov 7, 2025 at 7:37 AM#19

One thing that is still open after TirzTom’s answer:

What did you change at the same time, and can you separate the two now?

28 1lori_vegas, Dr.PulmRoch, maya_sedona and 25 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Nov 9, 2025 at 3:39 AM#20

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. No action needed from anybody.

50 23PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 47 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register